Clinical Trial Update: directSTIM™ Deep Brain Stimulation System Post-Market Clinical Follow-up Study on Essential Tremor

View source ↗

Summary

Post-market clinical follow-up study of the directSTIM Deep Brain Stimulation System for essential tremor has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Tremor

Drugs mentioned

• directSTIM Deep Brain Stimulation System

Snippet

Sponsor: Aleva Neurotherapeutics SA | Conditions: Essential Tremor | Status: TERMINATED